AJP - Heart AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 294: H14-H15, 2008. First published November 9, 2007; doi:10.1152/ajpheart.01297.2007
0363-6135/08 $8.00
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/1/H14    most recent
01297.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edwards, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edwards, J. G.

EDITORIAL FOCUS

Cardiac MHC gene expression: more complexity and a step forward

John G. Edwards

Department of Physiology, New York Medical College, Valhalla, New York

WITHIN CARDIAC MUSCLE, the myosin heavy chain (MHC) protein is a major component of the contractile machinery. MHC provides structural integrity, and its isoform is a major determinant of contractile and functional properties of the myocardium (1, 8). Cardiac MHC isoforms exist as homologous or heterologous dimers, and a unique gene product encodes each. At the genomic level, {alpha}- and β-MHC genes are organized in tandem over a 60-kb region on human chromosome 14 (18). At the protein level, the cardiac {alpha}- and β-MHC proteins have a high degree (94%) of sequence identity, and divergence only occurs in clusters of functionally important regions such as the ATPase catalytic site (16). Although the human heart expresses predominantly the β-MHC protein, a small but significant amount of {alpha}-MHC is present. The proportion of {alpha}-MHC has been shown to decline in the failing human heart, which is likely to contribute to a decline in cardiac performance (14, 17).

Studies focusing on the thyroid hormone (3,5,3'-triiodothyronine, T3) regulation of cardiac MHC transcription have spanned more than two decades (13). Earlier efforts to elucidate the mechanisms for T3-induced changes in MHC transcription have ranged from variable for the control of {alpha}-MHC transcription to less than satisfying for the control of β-MHC transcription (2, 4, 19). These studies and others examined regulation of a single gene, whereby an activated T3 receptor binds to the "promoter region" of a gene to modify its transcription. The levels of complexity were elevated by observations that T3-induced changes in MHC transcription were modified by the participation of alternatively spliced T3 receptors and that T3 receptors were able to form homo- or heterodimers with other members of the steroid receptor family, permitting many combinations that could influence cardiac MHC transcription (10).

In their recent article in the American Journal of Physiology-Heart and Circulatory Physiology, Haddad et al. (7a) argue for a coordinated regulation that spans both gene products, viewing them as a single regulated entity. The authors have made use of strand-specific reverse transcription of RNA to examine both developmental and hormonally induced changes in cardiac MHC gene transcription. Previously this group had demonstrated the presence of an antisense β-MHC transcript whose expression was increased by both hypothyroidism and pressure overload (6, 7). In their present study increases in the antisense β-MHC transcript following birth or in response to increases in T3 inversely matched changes in β-MHC mRNA levels. This suggests an alternative to a T3 receptor-mediated interaction within the promoter region of the β-MHC gene, as a controlling function of β-MHC expression. The antisense β-MHC RNA transcript originated from transcription initiated in the intergenic (IG) region between the {alpha}-MHC and β-MHC coding regions. The present report by Haddad et al. extends those observations to show that transcription from the IG locus is bidirectional and that in addition to the antisense β-MHC transcript being synthesized, a sense IG RNA transcript that merges with the {alpha}-MHC pre-mRNA is also present. The sense IG RNA transcript is also sensitive to both thyroid state and developmental stage. Phylogenetic analyses of the IG region identified a highly conserved region of >80% across five species, located between the start sites that potentially may serve as a promoter region for the two transcripts.

The mechanisms by which each of these novel transcripts functions remain unclear. It has only recently been appreciated that bidirectional transcription is prevalent in the mammalian transcriptome, and its role and mechanisms remain to be elucidated (11). It is not known whether the antisense β-MHC transcript acts by RNA interference or whether it serves to modify transcriptional/translation processes by some other means. Alternatively, it may be that the antisense β-MHC transcript is further processed to generate a microRNA. van Rooij et al. (20) recently reported a microRNA transcript from {alpha}-MHC intron 27. The miR-208 also participated in T3 repression of β-MHC expression, possibly through an interaction with the THRAP1 protein. And it remains to be determined whether the antisense β-MHC transcript operates similarly. The role of the sense IG transcript also remains unresolved. Dennehey et al. (3) identified alternative transcription start sites and alternative splicing for several striated muscle MHC genes including the {alpha}-MHC and β-MHC genes. The alternative transcripts were localized only to the 5' untranslated regions (UTR) and not the coding regions. Their findings are significant since the presence of alternative 5'UTR could directly impact on mRNA stability or translation initiation, which is the rate-limiting step for translation. In the present study of Haddad et al., the sense IG transcript and the mature {alpha}-MHC-mRNA transcript appear equally sensitive to T3; however, developmentally they appear to move in different directions. Whether this is a mechanism of development or reflective of developmental processes also remains to be determined.

The authors' argument for viewing the MHC genes as a single regulated entity is timely. A great deal more is now understood about the role of chromatin structure in transcriptional regulation (15). Earlier studies demonstrated that the cardiac MHC genes were DNase sensitive and that this sensitivity could by altered by T3, suggesting a potential role for chromatin remodeling (9). More recently, studies focusing on histone acetylation have demonstrated a significant role for chromatin remodeling in mediating the myocardial response to cardiac overload (12). Thyroid hormone effects could be mediated by the thyroid-associated proteins (TRAPs), which are known to interact with members of the transcriptional complex and have intrinsic acetylation activity (5). The phylogenic analyses of the intergenic MHC region as reported by Haddad et al. (7a) identified an abundance of T3 receptor (T3R)/retinoic acid receptor (RAR/RXR) binding sites within the IG region that could mediate T3-induced alterations but also serve as a focal point for the epigenetic regulation of the MHC genes.

At the genomic level, {alpha}- and β-MHC genes are organized in tandem over a 60-kb region on human chromosome 14, while the six skeletal MHC genes are found over a 600-kb span on human chromosome 17 (21). Understanding the mechanisms of transcriptional regulation of the cardiac genes not only will increase our understanding of cardiac physiology but will provide a conceptual basis for a more complete understanding of transcriptional regulation of the skeletal MHC genes.

GRANTS

This work was supported in part by National Heart, Lung, and Blood Institute Grant PO1-HL-43023 and the New York Medical College Research Endowment Fund.

FOOTNOTES


Address for reprint requests and other correspondence: J. G. Edwards, Dept. of Physiology, New York Medical College, Valhalla, NY 10595 (e-mail: j_edwards{at}nymc.edu)

REFERENCES

  1. Buccino RA, Spann JF Jr, Sonnenblick EH, Braunwald E. Effect of thyroid state on myocardial contractility. Endocrinology 82: 191–192, 1968.[Abstract/Free Full Text]
  2. Buttrick PM, Kaplan ML, Kitsis RN, Leinwand LA. Distinct behavior of cardiac myosin heavy chain gene constructs in vivo. Discordance with in vitro results. Circ Res 72: 1211–1217, 1993.[Abstract/Free Full Text]
  3. Dennehey BK, Leinwand LA, Krauter KS. Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts. J Muscle Res Cell Motil 27: 559–575, 2006.[CrossRef][Web of Science][Medline]
  4. Edwards JG, Bahl JJ, Flink I, Milavetz J, Morkin E. A repressor region in the human beta myosin heavy chain gene that has a partial position dependency. Biochem Biophys Res Commun 189: 504–510, 1992.[CrossRef][Web of Science][Medline]
  5. Gusterson RJ, Jazrawi E, Adcock IM, Latchman DS. The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity. J Biol Chem 278: 6838–6847, 2003.[Abstract/Free Full Text]
  6. Haddad F, Bodell PW, Qin AX, Giger JM, Baldwin KM. Role of antisense RNA in coordinating cardiac myosin heavy chain gene switching. J Biol Chem 278: 37132–37138, 2003.[Abstract/Free Full Text]
  7. Haddad F, Qin AX, Bodell PW, Zhang LY, Guo H, Giger JM, Baldwin KM. Regulation of antisense RNA expression during cardiac MHC gene switching in response to pressure overload. Am J Physiol Heart Circ Physiol 290: H2351–H2361, 2006.[Abstract/Free Full Text]
  8. Haddad F, Qin AX, Bodell PW, Jiang W, Giger JM, Baldwin KM. Intergenic transcription and developmental regulation of cardiac myosin heavy chain genes. Am J Physiol Heart Circ Physiol (November 2, 2007). doi:10.1152/ajpheart.01125.2007.
  9. Herron TJ, Korte FS, McDonald KS. Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression. Am J Physiol Heart Circ Physiol 281: H1217–H1222, 2001.[Abstract/Free Full Text]
  10. Huang WY, Liew CC. Chromatin remodelling of the cardiac beta-myosin heavy chain gene. Biochem J 330: 871–876, 1998.[Web of Science][Medline]
  11. Izumo S, Mahdavi V. Thyroid hormone receptor alpha isoforms generated by alternative splicing differentially activate myosin HC gene transcription. Nature 334: 539–542, 1988.[CrossRef][Medline]
  12. Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M, Nakamura M, Nishida H, Yap CC, Suzuki M, Kawai J, Suzuki H, Carninci P, Hayashizaki Y, Wells C, Frith M, Ravasi T, Pang KC, Hallinan J, Mattick J, Hume DA, Lipovich L, Batalov S, Engstrom PG, Mizuno Y, Faghihi MA, Sandelin A, Chalk AM, Mottagui-Tabar S, Liang Z, Lenhard B, Wahlestedt C. Antisense transcription in the mammalian transcriptome. Science 309: 1564–1566, 2005.[Abstract/Free Full Text]
  13. Kong Y, Tannous P, Lu G, Berenji K, Rothermel BA, Olson EN, Hill JA. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113: 2579–2588, 2006.[Abstract/Free Full Text]
  14. Lompre AM, Nadal-Ginard B, Mahdavi V. Expression of the cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally and hormonally regulated. J Biol Chem 259: 6437–6446, 1984.[Abstract/Free Full Text]
  15. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, Badesch DB, Groves BM, Gilbert EM, Bristow MR. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 100: 2315–2324, 1997.[Web of Science][Medline]
  16. McKinsey TA, Olson EN. Cardiac histone acetylation—therapeutic opportunities abound. Trends Genet 20: 206–213, 2004.[CrossRef][Web of Science][Medline]
  17. McNally EM, Kraft R, Bravo-Zehnder M, Taylor DA, Leinwand LA. Full-length rat alpha and beta cardiac myosin heavy chain sequences. Comparisons suggest a molecular basis for functional differences. J Mol Biol 210: 665–671, 1989.[CrossRef][Web of Science][Medline]
  18. Miyata S, Minobe W, Bristow MR, Leinwand LA. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res 86: 386–390, 2000.[Abstract/Free Full Text]
  19. Saez LJ, Gianola KM, McNally EM, Feghali R, Eddy R, Shows TB, Leinwand LA. Human cardiac myosin heavy chain genes and their linkage in the genome. Nucleic Acids Res 15: 5443–5459, 1987.[Abstract/Free Full Text]
  20. Tsika RW, Bahl JJ, Leinwand LA, Morkin E. Thyroid hormone regulates expression of a transfected human alpha-myosin heavy chain fusion gene in fetal rat heart cells. Proc Natl Acad Sci USA 87: 379–383, 1990.[Abstract/Free Full Text]
  21. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316: 575–579, 2007.[Abstract/Free Full Text]
  22. Yoon SJ, Seiler SH, Kucherlapati R, Leinwand L. Organization of the human skeletal myosin heavy chain gene cluster. Proc Natl Acad Sci USA 89: 12078–12082, 1992.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/1/H14    most recent
01297.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edwards, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edwards, J. G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.